Copyright © 1997 by the European Society of Cardiology.
© 1997 The European Society of Cardiology
C-reactive protein as a marker for acute coronary syndromes
,




Cardiology Center, Department of Medicine, University Hospital Geneva, Switzerland
Clinic of Medicine, Department of Medicine, University Hospital Geneva, Switzerland
Emergency Center, Department of Medicine, University Hospital Geneva, Switzerland
||Central Clinical Chemistry Laboratory, Department of Medicine, University Hospital Geneva, Switzerland
Received 26 June 1997; accepted 10 July 1997.
Correspondence: François Mach, Vascular Medicine and Atherosclerosis Unit, Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue, LMRC 309, Boston, MA 02115, U.S.A.
Abstract
BACKGROUND: For several years, acute coronary syndromes have been perceived as causing the most hospital admissions, and even hospital mortality. The syndrome of unstable angina frequently progresses to acute myocardial infarction but its pathogenesis is poorly understood, and prognosis determination is still problematic. We tested the hypothesis that measurement of the C-reactive protein in patients admitted for chest pain could be a marker for acute coronary syndromes.
METHODS AND RESULTS: We studied 110 patients admitted with suspected ischaemic heart disease, but without elevated serum creatine-kinase levels at the time of hospital admission. Patients were subsequently divided into two groups based on their final diagnosis: group 1 comprised patients with unstable angina; group 2 patients with acute myocardial infarction. We measured the C-reactive protein at the time of hospital admission. The concentration of C-reactive protein was elevated in 59% of the patients with a final diagnosis of acute myocardial infarction, and in 5% of the patients with a final diagnosis of unstable angina, (P<0·001).
CONCLUSION: This study indicates that C-reactive protein levels measured at the time of admission in patients with suspected ischaemic heart disease could be a marker for acute coronary syndromes, and helpful in identifying patients at high risk for acute myocardial infarction. Measurement of C-reactive protein may have practical clinical significance in the management of patients hospitalized for suspected acute coronary syndromes.
Key Words: Acute coronary syndromes C-reactive protein
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. F. Keaney Jr Circulating Biomarkers in Acute Coronary Syndromes: Something Different or More of the Same? Circulation, August 9, 2005; 112(6): 778 - 780. [Full Text] [PDF] |
||||
![]() |
K. Hayashida, N. Kume, T. Murase, M. Minami, D. Nakagawa, T. Inada, M. Tanaka, A. Ueda, G. Kominami, H. Kambara, et al. Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Elevated in Acute Coronary Syndrome: A Novel Marker for Early Diagnosis Circulation, August 9, 2005; 112(6): 812 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. O'Rourke, J. S. Hochman, M. C. Cohen, C. L. Lucore, J. J. Popma, and C. P. Cannon New Approaches to Diagnosis and Management of Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction Arch Intern Med, March 12, 2001; 161(5): 674 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques Am. J. Pathol., March 1, 2001; 158(3): 1039 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Taaffe, T. B. Harris, L. Ferrucci, J. Rowe, and T. E. Seeman Cross-sectional and Prospective Relationships of Interleukin-6 and C-Reactive Protein With Physical Performance in Elderly Persons: MacArthur Studies of Successful Aging J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2000; 55(12): 709M - 715. [Abstract] [Full Text] |
||||
![]() |
P. Holvoet, D. Collen, and F. Van de Werf Malondialdehyde-Modified LDL as a Marker of Acute Coronary Syndromes JAMA, May 12, 1999; 281(18): 1718 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Halon, M. Y. Flugelman, A. Merdler, H. Rennert, J. Shahla, and B. S. Lewis Long-term (10-year) outcome in patients with unstable angina pectoris treated by coronary balloon angioplasty J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1603 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Danesh, R. Collins, P. Appleby, and R. Peto Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease: Meta-analyses of Prospective Studies JAMA, May 13, 1998; 279(18): 1477 - 1482. [Abstract] [Full Text] [PDF] |
||||





